Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy

Fetal Diagnosis and Therapy

Volumn 22, Issue 6, 2007, Pages 444-448

  Galanakis, Emmanouil ^a,b   Manoura, Antonia ^a   Antoniou, Maria ^a   Sifakis, Stavros ^a   Korakaki, Eftichia ^a   Hatzidaki, Eleftheria ^a   Lambraki, Dimitra ^a   Tselentis, Yiannis ^a   Giannakopoulou, Christina ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Congenital infections; Parasitoses; Prenatal screening; Toxoplasmosis

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN G; PYRIMETHAMINE; SULFADIAZINE;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GREECE; HUMAN; INFANCY; INFANT; LABOR; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PREGNANCY; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SPIRAMYCIN; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; TREATMENT OUTCOME;

EID: 35548980005     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106352     Document Type: Article

References (20)

1. Wallon M, Liou C, Garner P, Peyron F: Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999;318:1511-1514.
2. Wong SY, Remington JS: Toxoplasmosis in pregnancy. Clin Infect Dis 1994;18:853-862.
3. Kravetz JD, Federman DG: Toxoplasmosis in pregnancy. Am J Med 2005;118:212-216.
4. Gilbert RE, Stanford MR: Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 2000;84:224-226.
5. Gras L, Gilbert RE, Ades AE, Dunn DT: Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001;30:1309-1313.
6. Gratzl R, Hayde M, Kohlhauser C, Hermon M, Burda G, Strobl W, Pollak A: Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbiol Infect Dis 1998;17:853-858.
7. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, Trenque T, Schmit G, Quereux C, Guenounou M, Pluot M, Bonhomme A, Pinon JM: Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998;30:295-300.
8. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E: Classification system and case definition of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Microbiol Infect Dis 1996;15:799-805.
9. Mombro P, Perathoner C, Leone A, Buttafuoco V, Zotti C, Lievre MA, Fabris C: Congenital toxoplasmosis: assessment of risk to newborns in confirmed and uncertain maternal infection. Eur J Pediatr 2003;162:703-706.
10. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R, Toxoplasmosis Study Group: Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol 2005;192:564-571.
11. Antsaklis A, Daskalakis G, Papantoniou N, Mentis A, Michalas S: Prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 2002;22:1107-1111.
12. Antoniou M, Tzouvali H, Sifakis S, Galanakis E, Georgopoulou E, Liakou V, Giannakopoulou C, Koumantakis E, Tselentis Y: Incidence of toxoplasmosis in 5,532 pregnant women in Crete, Greece: management of 185 cases at risk. Eur J Obstet Gynecol Reprod Biol 2004;117:138-143.
13. Buffolano W, Lappalainen M, Hedman L, Ciccimarra F, Del Pezzo M, Rescaldani R, Gargano N, Hedman K: Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2004;23:825-830.
14. Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet 2004;363:1965-1976.
15. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, Remington JS: False-positive results in immunoglobulin M Toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997;35:174-178.
16. Rilling V, Dietz K, Krczal D, Knotek F, Enders G: Evaluation of a commercial IgG/ IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003;22:174-180.
17. Nielsen HV, Schmidt DR, Petersen E: Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin G profiles. J Clin Microbiol 2005;43:711-715.
18. Gilbert R, Gras L, European Multicentre Study on Congenital Toxoplasmosis: Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003;110:112-120.
19. Wallon M, Cozon G, Ecochard R, Lewin P, Peyron F: Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 2001;160:534-540.
20. Corvaisier S, Charpiat B, Mounier C, Wallon M, Leboucher G, Al Kurdi M, Chaulet JF, Peyron F: Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis. Antimicrob Agents Chemother 2004;48:3794-3800.